Seetrials: Leveraging Large Language Models for Safety and Efficacy Extraction in Oncology Clinical Trials
Kyeryoung Lee(Intelligent Medical Objects (United States)), Xiaoyan Wang(Yantai University), Mary Kwok(National Cancer Institute), Liang‐Chin Huang(Dairy Management), Samuel M. Rubinstein(Vanderbilt University Medical Center), Hua Xu(Tohoku University), C. Beau Hilton(Vanderbilt University), Surabhi Datta, Jingqi Wang(Intelligent Medical Objects (United States)), Andrew J. Cowan(University of Washington), J. Higashi(Dairy Management), Hunki Paek, Nneka Ofoegbu, Jeremy L. Warner(Brown University)
Cited by 5
Related Papers
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
|The Lancet|2020|1.8k
Treatment With Carfilzomib-Lenalidomide-Dexamethasone With Lenalidomide Extension in Patients With Smoldering or Newly Diagnosed Multiple Myeloma
|JAMA Oncology|2015|309
Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19
|JAMA Oncology|2021|185
Use of Natural Language Processing to Extract Clinical Cancer Phenotypes from Electronic Medical Records
|Cancer Research|2019|175
PDBe-KB: a community-driven resource for structural and functional annotations
|Nucleic Acids Research|2019|138